Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Current Deferred Revenue (2018 - 2025)

DarioHealth filings provide 11 years of Current Deferred Revenue readings, the most recent being $714000.0 for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 54.9% to $714000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $714000.0, a 54.9% decrease, with the full-year FY2025 number at $714000.0, down 54.9% from a year prior.
  • Current Deferred Revenue hit $714000.0 in Q4 2025 for DarioHealth, down from $893000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.8 million in Q1 2024 to a low of $684000.0 in Q3 2023.
  • Median Current Deferred Revenue over the past 5 years was $1.1 million (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Current Deferred Revenue: soared 93.62% in 2024 and later plummeted 54.9% in 2025.
  • DarioHealth's Current Deferred Revenue stood at $1.2 million in 2021, then rose by 10.46% to $1.3 million in 2022, then fell by 24.47% to $997000.0 in 2023, then skyrocketed by 58.78% to $1.6 million in 2024, then plummeted by 54.9% to $714000.0 in 2025.
  • The last three reported values for Current Deferred Revenue were $714000.0 (Q4 2025), $893000.0 (Q3 2025), and $727000.0 (Q2 2025) per Business Quant data.